Physician profile
Jason Robert Dudas
NPI 1427253244
$7,007.53
in general payments reported to CMS, 2019-2025
16 companies · $1,228 in 2025
The $1,228 reported for 2025 was more than what 77% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,024 · 2020: $925 · 2021: $880 · 2022: $1,254 · 2023: $1,005 · 2024: $691 · 2025: $1,228.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,925.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,925.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $3,237.83 | 2019-2025 | |
| Mentor Worldwide LLC | $1,517.97 | 2021-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Abbvie INC. | $346.24 | 2022-2025 | |
| Stryker Corporation | $301.51 | 2025 | Spy-Phi System, Cascadia Interbody System |
| Sientra, INC. | $236.49 | 2019-2020 | |
| Innovation Technologies INC | $183.15 | 2025 | Irrisept |
| Davol INC. | $157.05 | 2020-2024 | Phasix Mesh |
| Solventum Corporation | $153.29 | 2025 | Prevena, V.A.C. Veraflo Cleanse Choice |
| Medical Device Business Services, INC. | $146.05 | 2024 | |
| Tepha INC | $136.10 | 2019 | |
| Derma Sciences, INC. | $123.04 | 2019 | |
| Allergan, INC. | $119.87 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $118.24 | 2025 | Gattex |
| Integra Lifesciences Corporation | $116.28 | 2020-2022 | |
| W. L. Gore & Associates, INC. | $100.72 | 2024 | Gore Enform Preperitoneal Biomaterial |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $13.70 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Dudas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.